E2 inhibited the growth of renal cell carcinoma in an estrogen receptor (ER)-dependent pathway [30], and on the contrary, dihydrotestosterone (DHT) promoted renal carcinoma growth [31] via androgen receptors. The gene discussed is ESR1; the disease is renal carcinoma.